...
首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Physician Visits and 30-Day Hospital Readmissions in Patients Receiving Hemodialysis
【24h】

Physician Visits and 30-Day Hospital Readmissions in Patients Receiving Hemodialysis

机译:接受血液透析患者的内科医生就诊和30天医院再入院

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Afocus of health care reform has been on reducing 30-day hospital readmissions. Patients with ESRD are at high risk for hospital readmission. It is unknown whether more monitoring by outpatient providers can reduce hospital readmissions in patients receiving hemodialysis. In nationally representative cohorts of patients in the United States receiving in-center hemodialysis between 2004 and 2009, we used a quasi-experimental (instrumental variable) approach to assess the relationship between frequency of visits to patients receiving hemodialysis following hospital discharge and the probability of rehospitalization. We then used a multivariable regression model and published hospitalization data to estimate the cost savings and number of hospitalizations that could be prevented annually with additional provider visits to patients in the month following hospitalization. In the main cohort (n=26,613), one additional provider visit in the month following hospital discharge was estimated to reduce the absolute probability of 30-day hospital readmission by 3.5% (95% confidence interval, 1.6% to 5.3%). The reduction in 30-day hospital readmission ranged from 0.5% to 4.9% in an additional four cohorts tested, depending on population density around facilities, facility profit status, and patient Medicaid eligibility. At current Medicare reimbursement rates, the effort to visit patients one additional time in the month following hospital discharge could lead to 31,370 fewer hospitalizations per year, and $240 million per year saved. In conclusion, more frequent physician visits following hospital discharge are estimated to reduce rehospitalizations in patients undergoing hemodialysis. Incentives for closer outpatient monitoring following hospital discharge could lead to substantial cost savings.
机译:医疗保健改革的重点一直是减少30天的住院率。 ESRD患者有再次入院的高风险。尚不明确的是,门诊提供者的更多监视是否可以减少接受血液透析的患者的住院率。在2004年至2009年间接受中心血液透析的美国患者的全国代表性队列中,我们使用准实验(仪器变量)方法评估了出院后接受血液透析患者的就诊频率与患病可能性之间的关系。再次住院。然后,我们使用多变量回归模型并发布了住院数据,以估计节省费用和住院次数,而在住院后一个月中,通过对患者进行额外的提供者探视,每年可以避免的费用节省和住院次数。在主要队列(n = 26,613)中,估计出院后一个月又有一次服务提供者就诊,可使30天再次入院的绝对可能性降低3.5%(95%置信区间,从1.6%至5.3%)。在另外四个接受测试的队列中,根据设施周围的人口密度,设施的获利状况以及患者的医疗补助资格,将30天住院再住院的减少幅度从0.5%降低至4.9%。按照目前的Medicare报销比例,在出院后一个月再看一次病人的努力每年可减少31,370例住院治疗,每年可节省2.4亿美元。总之,据估计,出院后更频繁的就诊可以减少血液透析患者的再次住院。出院后鼓励进行更密切的门诊监测的激励措施可以节省大量成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号